ATC code N02: Difference between revisions
Jump to navigation
Jump to search
imported>Whywhenwhohow 2025 additions |
imported>Whywhenwhohow add entries, anchors |
||
| Line 1: | Line 1: | ||
{{ATC codes lead|N|02|Analgesics|vet=add}} | {{ATC codes lead|N|02|Analgesics|vet=add}} | ||
== | ==<span class="anchor" id="N02A"></span>N02A [[Opioid]]s== | ||
=== | ===<span class="anchor" id="N02AA"></span>N02AA Natural opium alkaloids=== | ||
:N02AA01 [[Morphine]] | :N02AA01 [[Morphine]] | ||
:N02AA02 [[Opium]] | :N02AA02 [[Opium]] | ||
| Line 20: | Line 20: | ||
:N02AA79 [[Codeine]], combinations with [[Psycholeptic|psycholeptics]] | :N02AA79 [[Codeine]], combinations with [[Psycholeptic|psycholeptics]] | ||
=== | ===<span class="anchor" id="N02AB"></span>N02AB [[Phenylpiperidine]] derivatives=== | ||
:N02AB01 [[Ketobemidone]] | :N02AB01 [[Ketobemidone]] | ||
:N02AB02 [[Pethidine]] | :N02AB02 [[Pethidine]] | ||
| Line 29: | Line 29: | ||
:QN02AB73 [[Fentanyl]], combinations with [[Psycholeptic|psycholeptics]] | :QN02AB73 [[Fentanyl]], combinations with [[Psycholeptic|psycholeptics]] | ||
=== | ===<span class="anchor" id="N02AC"></span>N02AC [[Diphenylpropylamine]] derivatives=== | ||
:N02AC01 [[Dextromoramide]] | :N02AC01 [[Dextromoramide]] | ||
:N02AC03 [[Piritramide]] | :N02AC03 [[Piritramide]] | ||
| Line 39: | Line 39: | ||
:QN02AC90 [[Methadone]] | :QN02AC90 [[Methadone]] | ||
=== | ===<span class="anchor" id="N02AD"></span>N02AD [[Benzomorphan]] derivatives=== | ||
:N02AD01 [[Pentazocine]] | :N02AD01 [[Pentazocine]] | ||
:N02AD02 [[Phenazocine]] | :N02AD02 [[Phenazocine]] | ||
:N02AD51 Pentazocine and [[naloxone]] | :N02AD51 Pentazocine and [[naloxone]] | ||
=== | ===<span class="anchor" id="N02AE"></span>N02AE [[Oripavine]] derivatives=== | ||
:N02AE01 [[Buprenorphine]] | :N02AE01 [[Buprenorphine]] | ||
:QN02AE90 [[Etorphine]] | :QN02AE90 [[Etorphine]] | ||
:QN02AE99 [[Oripavine]] derivatives, combinations | :QN02AE99 [[Oripavine]] derivatives, combinations | ||
=== | ===<span class="anchor" id="N02AF"></span>N02AF [[Morphinan]] derivatives=== | ||
:N02AF01 [[Butorphanol]] | :N02AF01 [[Butorphanol]] | ||
:N02AF02 [[Nalbuphine]] | :N02AF02 [[Nalbuphine]] | ||
=== | ===<span class="anchor" id="N02AG"></span>N02AG Opioids in combination with [[antispasmodic]]s=== | ||
:N02AG01 [[Morphine]] and [[Antispasmodic|antispasmodics]] | :N02AG01 [[Morphine]] and [[Antispasmodic|antispasmodics]] | ||
:N02AG02 [[Ketobemidone]] and [[Antispasmodic|antispasmodics]] | :N02AG02 [[Ketobemidone]] and [[Antispasmodic|antispasmodics]] | ||
| Line 59: | Line 59: | ||
:N02AG04 [[Hydromorphone]] and [[Antispasmodic|antispasmodics]] | :N02AG04 [[Hydromorphone]] and [[Antispasmodic|antispasmodics]] | ||
=== | ===<span class="anchor" id="N02AJ"></span>N02AJ Opioids in combination with non-opioid analgesics=== | ||
:N02AJ01 [[Dihydrocodeine]] and [[paracetamol]] | :N02AJ01 [[Dihydrocodeine]] and [[paracetamol]] | ||
:N02AJ02 [[Dihydrocodeine]] and [[acetylsalicylic acid]] | :N02AJ02 [[Dihydrocodeine]] and [[acetylsalicylic acid]] | ||
| Line 77: | Line 77: | ||
:N02AJ23 [[Hydrocodone/ibuprofen|Hydrocodone and ibuprofen]] | :N02AJ23 [[Hydrocodone/ibuprofen|Hydrocodone and ibuprofen]] | ||
=== | ===<span class="anchor" id="N02AX"></span>N02AX Other opioids=== | ||
:N02AX01 [[Tilidine]] | :N02AX01 [[Tilidine]] | ||
:N02AX02 [[Tramadol]] | :N02AX02 [[Tramadol]] | ||
| Line 86: | Line 86: | ||
:N02AX51 Tilidine and naloxone | :N02AX51 Tilidine and naloxone | ||
== | ==<span class="anchor" id="N02B"></span>N02B Other analgesics and [[antipyretic]]s== | ||
=== | ===<span class="anchor" id="N02BA"></span>N02BA [[Salicylic acid]] and derivatives=== | ||
:N02BA01 [[Acetylsalicylic acid]] | :N02BA01 [[Acetylsalicylic acid]] | ||
:N02BA02 [[Aloxiprin]] | :N02BA02 [[Aloxiprin]] | ||
| Line 115: | Line 115: | ||
:N02BA79 [[Dipyrocetyl]], combinations with [[Psycholeptic|psycholeptics]] | :N02BA79 [[Dipyrocetyl]], combinations with [[Psycholeptic|psycholeptics]] | ||
=== | ===<span class="anchor" id="N02BB"></span>N02BB [[Pyrazolone]]s=== | ||
:N02BB01 [[Phenazone]] | :N02BB01 [[Phenazone]] | ||
:N02BB02 [[Metamizole]] | :N02BB02 [[Metamizole]] | ||
| Line 130: | Line 130: | ||
:N02BB74 [[Propyphenazone]], combinations with [[Psycholeptic|psycholeptics]] | :N02BB74 [[Propyphenazone]], combinations with [[Psycholeptic|psycholeptics]] | ||
=== | ===<span class="anchor" id="N02BE"></span>N02BE [[Anilide]]s=== | ||
:N02BE01 [[Paracetamol]] | :N02BE01 [[Paracetamol]] | ||
:N02BE03 [[Phenacetin]] | :N02BE03 [[Phenacetin]] | ||
| Line 142: | Line 142: | ||
:N02BE74 [[Bucetin]], combinations with [[Psycholeptic|psycholeptics]] | :N02BE74 [[Bucetin]], combinations with [[Psycholeptic|psycholeptics]] | ||
=== | ===<span class="anchor" id="N02BF"></span>N02BF Gabapentinoids=== | ||
:N02BF01 [[Gabapentin]] | :N02BF01 [[Gabapentin]] | ||
:N02BF02 [[Pregabalin]] | :N02BF02 [[Pregabalin]] | ||
:N02BF03 [[Mirogabalin]] | :N02BF03 [[Mirogabalin]] | ||
=== | ===<span class="anchor" id="N02BG"></span>N02BG Other analgesics and antipyretics=== | ||
:N02BG02 [[Rimazolium]] | :N02BG02 [[Rimazolium]] | ||
:N02BG03 [[Glafenine]] | :N02BG03 [[Glafenine]] | ||
| Line 160: | Line 160: | ||
:QN02BG90 [[Frunevetmab]] | :QN02BG90 [[Frunevetmab]] | ||
:QN02BG91 [[Bedinvetmab]] | :QN02BG91 [[Bedinvetmab]] | ||
:QN02BG92 [[Relfovetmab]] | |||
:QN02BG93 [[Izenivetmab]] | |||
== | ==<span class="anchor" id="N02C"></span>N02C Anti[[migraine]] preparations== | ||
=== | ===<span class="anchor" id="N02CA"></span>N02CA Ergot alkaloids=== | ||
:N02CA01 [[Dihydroergotamine]] | :N02CA01 [[Dihydroergotamine]] | ||
:N02CA02 [[Ergotamine]] | :N02CA02 [[Ergotamine]] | ||
| Line 172: | Line 174: | ||
:N02CA72 [[Ergotamine]], combinations with [[Psycholeptic|psycholeptics]] | :N02CA72 [[Ergotamine]], combinations with [[Psycholeptic|psycholeptics]] | ||
=== | ===<span class="anchor" id="N02CB"></span>N02CB Corticosteroid derivatives=== | ||
:N02CB01 [[Flumedroxone]] | :N02CB01 [[Flumedroxone]] | ||
=== | ===<span class="anchor" id="N02CC"></span>N02CC [[Triptan|Selective serotonin (5-HT<sub>1</sub>) agonists]]=== | ||
:N02CC01 [[Sumatriptan]] | :N02CC01 [[Sumatriptan]] | ||
:N02CC02 [[Naratriptan]] | :N02CC02 [[Naratriptan]] | ||
| Line 186: | Line 188: | ||
:N02CC51 [[Sumatriptan/naproxen|Sumatriptan and naproxen]] | :N02CC51 [[Sumatriptan/naproxen|Sumatriptan and naproxen]] | ||
=== | ===<span class="anchor" id="N02CD"></span>N02CD [[Calcitonin gene-related peptide receptor antagonist|Calcitonin gene-related peptide (CGRP) antagonists]]=== | ||
:N02CD01 [[Erenumab]] | :N02CD01 [[Erenumab]] | ||
:N02CD02 [[Galcanezumab]] | :N02CD02 [[Galcanezumab]] | ||
| Line 196: | Line 198: | ||
:N02CD08 [[Zavegepant]] | :N02CD08 [[Zavegepant]] | ||
=== | ===<span class="anchor" id="N02CX"></span>N02CX Other antimigraine preparations=== | ||
:N02CX01 [[Pizotifen]] | :N02CX01 [[Pizotifen]] | ||
:N02CX02 [[Clonidine]] | :N02CX02 [[Clonidine]] | ||
Latest revision as of 05:43, 22 December 2025
N02A Opioids
N02AA Natural opium alkaloids
- N02AA01 Morphine
- N02AA02 Opium
- N02AA03 Hydromorphone
- N02AA04 Nicomorphine
- N02AA05 Oxycodone
- N02AA08 Dihydrocodeine
- N02AA10 Papaveretum
- N02AA11 Oxymorphone
- N02AA51 Morphine, combinations
- N02AA53 Hydromorphone and naloxone
- N02AA55 Oxycodone and naloxone
- N02AA56 Oxycodone and naltrexone
- N02AA58 Dihydrocodeine, combinations
- N02AA59 Codeine, combinations excluding psycholeptics
- N02AA79 Codeine, combinations with psycholeptics
N02AB Phenylpiperidine derivatives
- N02AB01 Ketobemidone
- N02AB02 Pethidine
- N02AB03 Fentanyl
- N02AB52 Pethidine, combinations excluding psycholeptics
- QN02AB53 Fentanyl, combinations excluding psycholeptics
- N02AB72 Pethidine, combinations with psycholeptics
- QN02AB73 Fentanyl, combinations with psycholeptics
N02AC Diphenylpropylamine derivatives
- N02AC01 Dextromoramide
- N02AC03 Piritramide
- N02AC04 Dextropropoxyphene
- N02AC05 Bezitramide
- N02AC52 Methadone, combinations excluding psycholeptics
- N02AC54 Dextropropoxyphene, combinations excluding psycholeptics
- N02AC74 Dextropropoxyphene, combinations with psycholeptics
- QN02AC90 Methadone
N02AD Benzomorphan derivatives
- N02AD01 Pentazocine
- N02AD02 Phenazocine
- N02AD51 Pentazocine and naloxone
N02AE Oripavine derivatives
- N02AE01 Buprenorphine
- QN02AE90 Etorphine
- QN02AE99 Oripavine derivatives, combinations
N02AF Morphinan derivatives
- N02AF01 Butorphanol
- N02AF02 Nalbuphine
N02AG Opioids in combination with antispasmodics
- N02AG01 Morphine and antispasmodics
- N02AG02 Ketobemidone and antispasmodics
- N02AG03 Pethidine and antispasmodics
- N02AG04 Hydromorphone and antispasmodics
N02AJ Opioids in combination with non-opioid analgesics
- N02AJ01 Dihydrocodeine and paracetamol
- N02AJ02 Dihydrocodeine and acetylsalicylic acid
- N02AJ03 Dihydrocodeine and other non-opioid analgesics
- N02AJ06 Codeine and paracetamol
- N02AJ07 Codeine and acetylsalicylic acid
- N02AJ08 Codeine and ibuprofen
- N02AJ09 Codeine and other non-opioid analgesics
- N02AJ13 Tramadol and paracetamol
- N02AJ14 Tramadol and dexketoprofen
- N02AJ15 Tramadol and other non-opioid analgesics
- N02AJ16 Tramadol and celecoxib
- N02AJ17 Oxycodone and paracetamol
- N02AJ18 Oxycodone and acetylsalicylic acid
- N02AJ19 Oxycodone and ibuprofen
- N02AJ22 Hydrocodone and paracetamol
- N02AJ23 Hydrocodone and ibuprofen
N02AX Other opioids
- N02AX01 Tilidine
- N02AX02 Tramadol
- N02AX03 Dezocine
- N02AX05 Meptazinol
- N02AX06 Tapentadol
- N02AX07 Oliceridine
- N02AX51 Tilidine and naloxone
N02B Other analgesics and antipyretics
N02BA Salicylic acid and derivatives
- N02BA01 Acetylsalicylic acid
- N02BA02 Aloxiprin
- N02BA03 Choline salicylate
- N02BA04 Sodium salicylate
- N02BA05 Salicylamide
- N02BA06 Salsalate
- N02BA07 Ethenzamide
- N02BA08 Morpholine salicylate
- N02BA09 Dipyrocetyl
- N02BA10 Benorilate
- N02BA11 Diflunisal
- N02BA12 Potassium salicylate
- N02BA14 Guacetisal
- N02BA15 Carbasalate calcium
- N02BA16 Imidazole salicylate
- N02BA51 Acetylsalicylic acid, combinations excluding psycholeptics
- N02BA55 Salicylamide, combinations excluding psycholeptics
- N02BA57 Ethenzamide, combinations excluding psycholeptics
- N02BA59 Dipyrocetyl, combinations excluding psycholeptics
- N02BA65 Carbasalate calcium combinations excluding psycholeptics
- N02BA67 Magnesium salicylate, combinations excluding psycholeptics
- N02BA71 Acetylsalicylic acid, combinations with psycholeptics
- N02BA75 Salicylamide, combinations with psycholeptics
- N02BA77 Ethenzamide, combinations with psycholeptics
- N02BA79 Dipyrocetyl, combinations with psycholeptics
N02BB Pyrazolones
- N02BB01 Phenazone
- N02BB02 Metamizole
- N02BB03 Aminophenazone
- N02BB04 Propyphenazone
- N02BB05 Nifenazone
- N02BB51 Phenazone, combinations excluding psycholeptics
- N02BB52 Metamizole sodium, combinations excluding psycholeptics
- N02BB53 Aminophenazone, combinations excluding psycholeptics
- N02BB54 Propyphenazone, combinations excluding psycholeptics
- N02BB71 Phenazone, combinations with psycholeptics
- N02BB72 Metamizole sodium, combinations with psycholeptics
- N02BB73 Aminophenazone, combinations with psycholeptics
- N02BB74 Propyphenazone, combinations with psycholeptics
N02BE Anilides
- N02BE01 Paracetamol
- N02BE03 Phenacetin
- N02BE04 Bucetin
- N02BE05 Propacetamol
- N02BE51 Paracetamol, combinations excluding psycholeptics
- N02BE53 Phenacetin, combinations excluding psycholeptics
- N02BE54 Bucetin, combinations excluding psycholeptics
- N02BE71 Paracetamol, combinations with psycholeptics
- N02BE73 Phenacetin, combinations with psycholeptics
- N02BE74 Bucetin, combinations with psycholeptics
N02BF Gabapentinoids
- N02BF01 Gabapentin
- N02BF02 Pregabalin
- N02BF03 Mirogabalin
N02BG Other analgesics and antipyretics
- N02BG02 Rimazolium
- N02BG03 Glafenine
- N02BG04 Floctafenine
- N02BG05 Viminol
- N02BG06 Nefopam
- N02BG07 Flupirtine
- N02BG08 Ziconotide
- N02BG09 Methoxyflurane
- N02BG10 Cannabinoids (includes nabiximols)
- N02BG12 Tanezumab
- QN02BG90 Frunevetmab
- QN02BG91 Bedinvetmab
- QN02BG92 Relfovetmab
- QN02BG93 Izenivetmab
N02C Antimigraine preparations
N02CA Ergot alkaloids
- N02CA01 Dihydroergotamine
- N02CA02 Ergotamine
- N02CA04 Methysergide
- N02CA07 Lisuride
- N02CA51 Dihydroergotamine, combinations
- N02CA52 Ergotamine, combinations excluding psycholeptics
- N02CA72 Ergotamine, combinations with psycholeptics
N02CB Corticosteroid derivatives
- N02CB01 Flumedroxone
N02CC Selective serotonin (5-HT1) agonists
- N02CC01 Sumatriptan
- N02CC02 Naratriptan
- N02CC03 Zolmitriptan
- N02CC04 Rizatriptan
- N02CC05 Almotriptan
- N02CC06 Eletriptan
- N02CC07 Frovatriptan
- N02CC08 Lasmiditan
- N02CC51 Sumatriptan and naproxen
- N02CD01 Erenumab
- N02CD02 Galcanezumab
- N02CD03 Fremanezumab
- N02CD04 Ubrogepant
- N02CD05 Eptinezumab
- N02CD06 Rimegepant
- N02CD07 Atogepant
- N02CD08 Zavegepant
N02CX Other antimigraine preparations
- N02CX01 Pizotifen
- N02CX02 Clonidine
- N02CX03 Iprazochrome
- N02CX05 Dimetotiazine
- N02CX06 Oxetorone
References
<templatestyles src="Reflist/styles.css" />
Script error: No such module "Check for unknown parameters".
Script error: No such module "navbox". Script error: No such module "Navbox".